
|Articles|July 1, 2002
Supplements and Featured Publications
- Symposium Reporter: Reaching Goal - Conquering the Treatment Gaps in Dyslipidemia
- Volume 8
- Issue 2 Symp
Changes in ATP III focus on diabetes and the metabolic syndrome
Author(s)H. Bryan Brewer, JR, MD
Advertisement
Articles in this issue
over 23 years ago
Statin Pharmacology May Have Important Clinical Implicationsover 23 years ago
Role of hs-CRP in Cardiovascular Risk Predictionover 23 years ago
Role of managed care in implementing NCEP-ATP III guidelinesover 23 years ago
Aggressive Lipid Reduction Provides Additional Clinical BenefitNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Accept Deidentified Real-World Evidence for Select Medical Device Applications
2
ACA Subsidy Expiration Raises Concerns for Behavioral Health Access and ED Strain
3
HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances
4
FDA Approves Intranasal Etripamil for Type of Arrhythmia
5









































